Elon Musk’s AI firm, xAI, is trying to figure out how to automate white-collar workers. In a recent podcast, a former engineer explained that xAI has been testing “human emulators,” which are AI systems designed to behave like real employees. These virtual workers are already being used internally and are listed on org charts just like humans. In some cases, real employees did not even realize they were interacting with AI.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Interestingly, the engineer, Sulaiman Ghori, said that these AI workers can sometimes cause confusion due to hallucinations or odd behaviors. For example, an AI might ask a coworker to come talk in person, only for that person to arrive at an empty desk. Notably, Ghori worked on xAI’s Macrohard team, which Elon Musk has described as an effort to build AI that can automatically create software. The long-term goal is to challenge traditional enterprise tools from companies like Microsoft (MSFT), but Ghori made it clear that much of the work today is still manual and customized on a case-by-case basis.
In addition, he explained that building virtual employees for customers is difficult because people often forget to describe all the small steps involved in their jobs. Therefore, to improve results, xAI is considering running as many as one million human emulators at once, potentially by using spare computing power from Tesla (TSLA) vehicles while they are charging.
What Is the Prediction for TSLA Stock?
When it comes to Elon Musk’s companies, most of them are privately held. However, retail investors can invest in his most popular company, Tesla. Turning to Wall Street, analysts have a Hold consensus rating on TSLA stock based on 12 Buys, 11 Holds, and seven Sells assigned in the past three months, as indicated by the graphic below. Furthermore, the average TSLA price target of $397.47 per share implies 6% downside risk.


